AIDS

AIDS
Gary van der Merwe · CC BY-SA 3.0 · source
Name	Acquired immunodeficiency syndrome
Symptoms	Opportunistic infections, weight loss, fever, night sweats
Causes	Human immunodeficiency virus (HIV)
Risks	Unprotected sex, contaminated needles, mother-to-child transmission, blood transfusion
Diagnosis	Antibody and antigen tests, nucleic acid tests, CD4 count
Treatment	Antiretroviral therapy
Prognosis	Improved with early treatment; chronic condition

AIDS AIDS is a clinical syndrome resulting from severe immune deficiency caused by infection with human immunodeficiency virus. It leads to life-threatening opportunistic infections, malignancies, and metabolic complications if untreated. Recognition of the syndrome transformed public health responses, biomedical research, and human rights activism across global institutions and national governments.

Introduction

The syndrome emerged into global awareness in the early 1980s during epidemiologic reports from centers such as the Centers for Disease Control and Prevention and prompted investigations by laboratories at Pasteur Institute, National Institutes of Health, and university clinics including Johns Hopkins University and University of California, San Francisco. Early activist organizations like Act Up and public figures including Rock Hudson and Freddie Mercury influenced public perception, policy debates in legislatures and courts, and funding decisions by foundations such as the Bill & Melinda Gates Foundation.

Virology and Pathogenesis

The causative agents belong to the genus Lentivirus in the family Retroviridae, with principal types named after geographic isolates initially characterized by teams at the Pasteur Institute and National Institutes of Health. Viral entry involves interaction with host receptors including CD4 and coreceptors such as CCR5 and CXCR4—discoveries related to collaborations among laboratories at institutions like Scripps Research and Columbia University Medical Center. Reverse transcription of viral RNA by reverse transcriptase and integration into host chromosomal DNA via integrase enable persistence; antiviral targets discovered at corporate laboratories including Gilead Sciences and GlaxoSmithKline informed drug development pipelines. Pathogenesis features progressive depletion of CD4 T cell populations, immune activation, and dysfunction of lymphoid organs such as the spleen and thymus.

Transmission and Prevention

Transmission occurs through sexual contact, exposure to infected blood and blood products, perinatal routes during pregnancy, delivery or breastfeeding, and occupational exposures documented in healthcare settings like World Health Organization safety guidelines. Prevention strategies include barrier methods promoted by public health campaigns led by agencies such as UNAIDS and Centers for Disease Control and Prevention; harm reduction interventions such as needle exchange programs supported by nonprofit organizations and municipal authorities; and biomedical prevention through pre-exposure prophylaxis developed by pharmaceutical firms with clinical trials run at centers like Massachusetts General Hospital and Imperial College London. Blood safety measures introduced after outbreaks involved national blood services and regulatory agencies such as the Food and Drug Administration.

Clinical Presentation and Diagnosis

Clinical manifestations range from acute retroviral syndrome described by clinicians at hospitals affiliated with Mount Sinai Health System to chronic immunodeficiency with opportunistic infections such as pneumocystis pneumonia identified in early case series from San Francisco General Hospital, and AIDS-defining cancers including Kaposi sarcoma identified by pathologists collaborating with institutions like Memorial Sloan Kettering Cancer Center. Diagnostic algorithms rely on antigen/antibody combination assays authorized by agencies such as Public Health England and nucleic acid amplification tests validated in multicenter studies including trials at Karolinska Institute and Johns Hopkins University. Prognostic staging incorporates CD4 T‑lymphocyte counts measured in laboratories at academic centers and viral load quantification standardized by international consortia including World Health Organization reference panels.

Treatment and Management

Antiretroviral therapy regimens combine agents from classes including nucleoside reverse transcriptase inhibitors developed by companies like Bristol-Myers Squibb, non-nucleoside reverse transcriptase inhibitors, protease inhibitors discovered in academic–industry partnerships, and integrase strand transfer inhibitors commercialized by firms such as Merck and Gilead Sciences. Treatment guidelines are regularly updated by panels convened by organizations such as World Health Organization and United States Department of Health and Human Services and implemented in clinics from tertiary centers like Mayo Clinic to community health centers. Management also addresses co-infections such as tuberculosis treated following protocols from World Health Organization and viral hepatitis managed according to recommendations from specialist societies like the American Association for the Study of Liver Diseases.

Epidemiology and History

Initial epidemic clusters were described in urban centers including New York City, San Francisco, and Kinshasa, prompting international investigations that traced viral origins to zoonotic transmission events in central Africa described by researchers at institutions such as University of Oxford and University of Cambridge. The global response included the creation of UNAIDS and large-scale funding mechanisms like the President's Emergency Plan for AIDS Relief and the Global Fund to Fight AIDS, Tuberculosis and Malaria. Epidemiologic surveillance by national public health agencies and research consortia updated burden estimates, with hotspots documented in regions such as sub-Saharan Africa and concentrated epidemics reported in metropolitan areas and among key populations in countries including Brazil, India, and Russia.

Social, Legal, and Economic Impact

The syndrome catalyzed civil society movements exemplified by organizations such as Act Up and influenced litigation in courts across jurisdictions including decisions by the Supreme Court of the United States and appellate courts affecting discrimination law and access to care. Public health financing debates engaged international institutions such as the World Bank and foundations including the Rockefeller Foundation. Stigma and human rights concerns mobilized advocacy through networks connected to Human Rights Watch and Amnesty International, while workplace and insurance policy responses involved national labor ministries and regulatory bodies. Pharmaceutical pricing controversies led to negotiations involving governments, trade agreements adjudicated at forums including the World Trade Organization, and generic manufacturing in countries such as India.

Category:Infectious diseases